Skip to main content
logo
Nectar Lifesciences Limited (NSE:NECLIFE)
India flag India · Delayed Price · Currency is INR
11.65
-0.28 (-2.35%)
Sep 11, 2026, 3:29 PM IST

Nectar Lifesciences Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
0.15--16,84615,23716,689
Revenue Growth
-100.00%--10.56%-8.70%8.13%
Gross Profit
0.01--4,6503,6444,457
Operating Income
-763.52-1,113-7.81928.4-51.721,016
Net Income
-2,451-2,929-1,13749.95-241.83250.47
Earnings Per Share
-11.60-13.40-5.070.22-1.081.12
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
1,2511,251197.52203.01178.94182.68
Total Debt
--5,8206,3557,5388,599
Net Cash (Debt)
1,2511,251-5,623-6,152-7,359-8,417
Net Cash Growth
------
Net Cash Per Share
5.925.73-25.07-27.43-32.82-37.53

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
--3,4871,6942,2471,337950.05
Capital Expenditures
--122.74-437.95-294.15-300.6-249.7
Free Cash Flow
--3,6101,2561,9531,036700.35
Free Cash Flow Growth
---35.66%88.50%47.91%-

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
5.52%--27.61%23.92%26.71%
Operating Margin
-526564.14%--5.51%-0.34%6.09%
Pretax Margin
-776784.83%--1.08%-2.78%2.04%
Profit Margin
-1690054.48%--0.30%-1.59%1.50%
FCF Margin
---11.59%6.80%4.20%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
---135.37-21.53
P/FCF Ratio
--4.103.463.457.70
PS Ratio
15406.90--0.400.240.32